Pediatric Orofacial and Laryngopharyngeal Rhabdomyosarcoma: An Intergroup Rhabdomyosarcoma Study Report

Moody D. Wharam; Mohan S. Beltangady; Ruth M. Heyn; Walter Lawrence; R. Beverly Raney; Frederick B. Ruymann; Edward H. Soule; Melvin Tefft; Harold M. Maurer

doi:10.1001/archotol.1987.01860110091014

Pediatric Orofacial and Laryngopharyngeal Rhabdomyosarcoma: An Intergroup Rhabdomyosarcoma Study Report

Moody D. Wharam, Mohan S. Beltangady, Ruth M. Heyn, Walter Lawrence, R. Beverly Raney, Frederick B. Ruymann, Edward H. Soule, Melvin Tefft, Harold M. Maurer

Pediatrics Hematology/Oncology

Research output: Contribution to journal › Article

34 Scopus citations

Abstract

Eighty-nine children with localized rhabdomyosarcoma of orofacial and laryngopharyngeal sites were treated in accordance with the first and second Intergroup Rhabdomyosarcoma Study (IRS) protocols (IRS-I and IRS-II) between 1972 and 1984. Treatment included surgery (or biopsy) and chemotherapy for all patients and radiotherapy in the majority. The actuarial estimate of the three-year survival rate for all patients was 83% and did not differ significantly by primary site, histologic findings, or presence of adenopathy. A trend for a worse survival rate was seen in clinical group III patients and in those less than 5 years of age at diagnosis. Factors associated with an increased risk of local/regional relapse included omission of radiotherapy and a radiation dose of less than 40 Gy (4000 rad). We conclude that treatment of these patients as recommended in the IRS-I and IRS-II protocols results in very good local and regional tumor control and survival rates. Salvage therapy for local/regional recurrence may yield long-term remission and possibly cure.

Original language	English (US)
Pages (from-to)	1225-1227
Number of pages	3
Journal	Archives of Otolaryngology--Head and Neck Surgery
Volume	113
Issue number	11
DOIs	https://doi.org/10.1001/archotol.1987.01860110091014
State	Published - Nov 1987

ASJC Scopus subject areas

Surgery
Otorhinolaryngology

Access to Document

10.1001/archotol.1987.01860110091014

Fingerprint Dive into the research topics of 'Pediatric Orofacial and Laryngopharyngeal Rhabdomyosarcoma: An Intergroup Rhabdomyosarcoma Study Report'. Together they form a unique fingerprint.

Cite this

Wharam, M. D., Beltangady, M. S., Heyn, R. M., Lawrence, W., Raney, R. B., Ruymann, F. B., Soule, E. H., Tefft, M., & Maurer, H. M. (1987). Pediatric Orofacial and Laryngopharyngeal Rhabdomyosarcoma: An Intergroup Rhabdomyosarcoma Study Report. Archives of Otolaryngology--Head and Neck Surgery, 113(11), 1225-1227. https://doi.org/10.1001/archotol.1987.01860110091014

Pediatric Orofacial and Laryngopharyngeal Rhabdomyosarcoma : An Intergroup Rhabdomyosarcoma Study Report. / Wharam, Moody D.; Beltangady, Mohan S.; Heyn, Ruth M.; Lawrence, Walter; Raney, R. Beverly; Ruymann, Frederick B.; Soule, Edward H.; Tefft, Melvin; Maurer, Harold M.

In: Archives of Otolaryngology--Head and Neck Surgery, Vol. 113, No. 11, 11.1987, p. 1225-1227.

Research output: Contribution to journal › Article

Wharam, Moody D. ; Beltangady, Mohan S. ; Heyn, Ruth M. ; Lawrence, Walter ; Raney, R. Beverly ; Ruymann, Frederick B. ; Soule, Edward H. ; Tefft, Melvin ; Maurer, Harold M. / Pediatric Orofacial and Laryngopharyngeal Rhabdomyosarcoma : An Intergroup Rhabdomyosarcoma Study Report. In: Archives of Otolaryngology--Head and Neck Surgery. 1987 ; Vol. 113, No. 11. pp. 1225-1227.

@article{6c1b49164a644110b1ff6075ae98b01a,

title = "Pediatric Orofacial and Laryngopharyngeal Rhabdomyosarcoma: An Intergroup Rhabdomyosarcoma Study Report",

abstract = "Eighty-nine children with localized rhabdomyosarcoma of orofacial and laryngopharyngeal sites were treated in accordance with the first and second Intergroup Rhabdomyosarcoma Study (IRS) protocols (IRS-I and IRS-II) between 1972 and 1984. Treatment included surgery (or biopsy) and chemotherapy for all patients and radiotherapy in the majority. The actuarial estimate of the three-year survival rate for all patients was 83% and did not differ significantly by primary site, histologic findings, or presence of adenopathy. A trend for a worse survival rate was seen in clinical group III patients and in those less than 5 years of age at diagnosis. Factors associated with an increased risk of local/regional relapse included omission of radiotherapy and a radiation dose of less than 40 Gy (4000 rad). We conclude that treatment of these patients as recommended in the IRS-I and IRS-II protocols results in very good local and regional tumor control and survival rates. Salvage therapy for local/regional recurrence may yield long-term remission and possibly cure.",

author = "Wharam, {Moody D.} and Beltangady, {Mohan S.} and Heyn, {Ruth M.} and Walter Lawrence and Raney, {R. Beverly} and Ruymann, {Frederick B.} and Soule, {Edward H.} and Melvin Tefft and Maurer, {Harold M.}",

year = "1987",

month = nov,

doi = "10.1001/archotol.1987.01860110091014",

language = "English (US)",

volume = "113",

pages = "1225--1227",

journal = "JAMA Otolaryngology - Head and Neck Surgery",

issn = "2168-6181",

publisher = "American Medical Association",

number = "11",

}

TY - JOUR

T1 - Pediatric Orofacial and Laryngopharyngeal Rhabdomyosarcoma

T2 - An Intergroup Rhabdomyosarcoma Study Report

AU - Wharam, Moody D.

AU - Beltangady, Mohan S.

AU - Heyn, Ruth M.

AU - Lawrence, Walter

AU - Raney, R. Beverly

AU - Ruymann, Frederick B.

AU - Soule, Edward H.

AU - Tefft, Melvin

AU - Maurer, Harold M.

PY - 1987/11

Y1 - 1987/11

N2 - Eighty-nine children with localized rhabdomyosarcoma of orofacial and laryngopharyngeal sites were treated in accordance with the first and second Intergroup Rhabdomyosarcoma Study (IRS) protocols (IRS-I and IRS-II) between 1972 and 1984. Treatment included surgery (or biopsy) and chemotherapy for all patients and radiotherapy in the majority. The actuarial estimate of the three-year survival rate for all patients was 83% and did not differ significantly by primary site, histologic findings, or presence of adenopathy. A trend for a worse survival rate was seen in clinical group III patients and in those less than 5 years of age at diagnosis. Factors associated with an increased risk of local/regional relapse included omission of radiotherapy and a radiation dose of less than 40 Gy (4000 rad). We conclude that treatment of these patients as recommended in the IRS-I and IRS-II protocols results in very good local and regional tumor control and survival rates. Salvage therapy for local/regional recurrence may yield long-term remission and possibly cure.

AB - Eighty-nine children with localized rhabdomyosarcoma of orofacial and laryngopharyngeal sites were treated in accordance with the first and second Intergroup Rhabdomyosarcoma Study (IRS) protocols (IRS-I and IRS-II) between 1972 and 1984. Treatment included surgery (or biopsy) and chemotherapy for all patients and radiotherapy in the majority. The actuarial estimate of the three-year survival rate for all patients was 83% and did not differ significantly by primary site, histologic findings, or presence of adenopathy. A trend for a worse survival rate was seen in clinical group III patients and in those less than 5 years of age at diagnosis. Factors associated with an increased risk of local/regional relapse included omission of radiotherapy and a radiation dose of less than 40 Gy (4000 rad). We conclude that treatment of these patients as recommended in the IRS-I and IRS-II protocols results in very good local and regional tumor control and survival rates. Salvage therapy for local/regional recurrence may yield long-term remission and possibly cure.

UR - http://www.scopus.com/inward/record.url?scp=0023574328&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023574328&partnerID=8YFLogxK

U2 - 10.1001/archotol.1987.01860110091014

DO - 10.1001/archotol.1987.01860110091014

M3 - Article

C2 - 3663351

AN - SCOPUS:0023574328

VL - 113

SP - 1225

EP - 1227

JO - JAMA Otolaryngology - Head and Neck Surgery

JF - JAMA Otolaryngology - Head and Neck Surgery

SN - 2168-6181

IS - 11

ER -